Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.0T | 5.5T | 6.0T | 5.5T |
Cost of revenue | 6.1T | 4.2T | 5.3T | 4.8T |
Gross profit | 937.3B | 1.3T | 722.1B | 701.5B |
Operating expense | ||||
Research & development | 6.0B | 5.2B | 5.4B | 5.2B |
Selling general and admin | 279.5B | 349.1B | 202.6B | 187.1B |
Other operating expenses | 181.3B | 142.7B | 37.2B | 53.1B |
Operating income | 411.8B | 808.0B | 433.4B | 398.9B |
Non operating interest income | ||||
Income | 62.1B | 61.3B | 66.0B | 48.2B |
Expense | 48.2B | 50.3B | 62.3B | 71.1B |
Other income expense | — | — | — | — |
Pretax income | 370.8B | 566.4B | 429.1B | 378.9B |
Tax provision | 85.9B | 209.9B | 120.3B | 97.4B |
Net income | 284.9B | 356.5B | 308.8B | 281.6B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 455.5B | 639.2B | 527.3B | 488.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -7.9B | -10.1B | -8.7B | -11.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |